Veterinary Medicines

Carepen vet 600 mg intramammary suspension for lactating cows

Authorised
  • Benzylpenicillin procaine monohydrate
Download as PDF

Product identification

Medicine name:
Carepen vet 600 mg intramammary suspension for lactating cows
Carepen vet 600 mg intramammarie, suspensjon til lakterende ku
Active substance:
  • Benzylpenicillin procaine monohydrate
Target species:
  • Cattle (lactating cow)
Route of administration:
  • Intramammary use

Product details

Active substance and strength:
  • Benzylpenicillin procaine monohydrate
    600.00
    milligram(s)
    /
    1.00
    Syringe
Pharmaceutical form:
  • Intramammary suspension
Withdrawal period by route of administration:
  • Intramammary use
    • Cattle (lactating cow)
      • Meat and offal
        3
        day
      • Milk
        6
        day
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QJ51CE09
Legal status of supply:
  • Veterinary medicinal product subject to veterinary prescription
Authorisation status:
  • Valid
Authorised in:
  • Norway
Package description:
  • Pack size: 100 x 10 g with 100 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 40 x 10 g with 40 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 20 x 10 g with 20 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 5 x 10 g with 5 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.
  • Pack size: 3 x 10 g with 3 cleaning towels. White intramammary syringe (LDPE) with a double tip (LDPE) packed in a cardboard container.

Additional information

Entitlement type:
  • Marketing Authorisation
Legal basis of product authorisation:
  • Generic application (Article 13(1) of Directive No 2001/82/EC)
Marketing authorisation holder:
  • Vetcare Oy
Marketing authorisation date:
Manufacturing sites for batch release:
  • Animedica GmbH
  • Kela - Kempisch Laboratorium - Kela Laboratoria
Responsible authority:
  • Norwegian Medical Products Agency
Authorisation number:
  • 19-13237
Date of authorisation status change:
Reference member state:
  • Finland
Procedure number:
  • FI/V/0110/001
Concerned member states:
  • Austria
  • Belgium
  • Denmark
  • Estonia
  • France
  • Germany
  • Iceland
  • Ireland
  • Italy
  • Latvia
  • Lithuania
  • Netherlands
  • Norway
  • Poland
  • Spain
  • Sweden
  • United Kingdom (Northern Ireland)

Documents

Summary of Product Characteristics

English (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download
Norwegian (PDF)
Published on: 26/09/2024
Download

Package Leaflet

English (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download
Norwegian (PDF)
Published on: 19/09/2023
Updated on: 21/09/2023
Download

Labelling

English (PDF)
Published on: 9/08/2023
Updated on: 10/08/2023
Download
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."